Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
Globe Life Inc. EVP & CFO Thomas Peter Kalmbach exercised employee stock options for 21,000 shares of common stock on July 30, 2026, at exercise prices of $103.23 and $120.49 per share, then sold 21,000 shares in transactions described as open market or private sales at prices ranging from $178.64 to $181.98 per share. After these trades, 1,158.515 shares were reported as held indirectly through a 401(k) Plan.
GLOBE LIFE INC. executive Michael Clay Majors, EVP and Chief Strategy Officer, exercised employee stock options for 37,000 shares of common stock on 2026-07-29 at an exercise price of $103.23 per share and immediately received 37,000 shares. On the same date, he sold 33,500 shares at a reported price of $178.5613 per share, with footnotes stating actual sale prices ranged from $178.115 to $179.04 per share, and sold an additional 3,500 shares at a reported price of $179.3490 per share within a range of $179.05 to $179.665 per share.
Globe Life EVP & CFO Thomas Peter Kalmbach reported option-related transactions dated 2026-07-28. He exercised employee stock options covering 25,650 shares of common stock at strike prices of $120.49 and $128.40, acquired the underlying shares, and then sold 25,650 shares in multiple open-market or private transactions at prices ranging from $177.31 to $179.52 per share. He also reports indirect ownership of 1,158.515 shares through a 401(k) plan. The Rule 10b5-1 trading-plan checkbox is unchecked.
Globe Life Inc. reporting person James Matthew Darden filed a notice of proposed sales of common stock under Form 144. The filing lists a planned sale of 50,000 NYSE-traded common shares, to be effected through Apex Clearing, with the transaction tied to a stock option exercise dated 07/29/2026.
The filer also reports prior sales of Globe Life common shares during the past three months, including 4,663 shares on 04/28/2026 for $717,529.84 and 22,019 shares on 05/05/2026 for $3,387,537.27.
Globe Life Inc shareholder Thomas Kalmbach filed a notice to sell up to 46,650 shares of Globe Life common stock, linked to a stock option exercise with an anticipated sale date of 07/27/2026. In the prior three months, he reported open-market sales including 11,790 shares for $1,792,362.96 on 05/08/2026 and 15,637 shares for $2,402,640.68 on 05/11/2026, along with two additional May transactions.
Globe Life Inc. reported diluted net income of $3.65 per share for the quarter ended June 30, 2026, up from $3.05 a year earlier, and net operating income of $3.61 per share versus $3.27.
Total premium revenue rose 7% to $1,297,622 thousand, while insurance underwriting income per share increased to $4.69 from $4.28 and excess investment income per share grew to $0.49 from $0.42. Management highlighted double-digit net operating income per share growth in eight of the last nine quarters.
For the six months, net income return on equity was 18.4%. Book value per share was $78.18, and $100.04 excluding accumulated other comprehensive income, up 18% and 11% respectively over the prior-year quarter. The company repurchased 1.1 million shares for $175 million and raised its full-year 2026 diluted EPS guidance to $15.55–$15.95.
GLOBE LIFE INC. executive Dolores L. Skarjune reported a same-day option exercise and share sale. She exercised employee stock options for 1,850 shares of common stock at $103.23 per share, then sold 1,850 shares in an open-market transaction at $179.18 per share.
After these transactions, she directly holds 13,696.734 common shares and has an additional 2,899.424 shares held indirectly through a 401(k) plan. No remaining stock options are shown in this filing, indicating the exercised option grant was fully converted.
Globe Life Inc. notice under Rule 144 reports a proposed sale of 1,850 shares of Common Stock by means of a stock option exercise with proceeds to the seller, dated 06/30/2026. The filing also records 4,175 shares sold in the prior three months for $693,793.98.
Globe Life Inc. has updated its main credit arrangements to extend maturities and increase term loan capacity. The company and subsidiary TMK Re Ltd. entered a Third Amended and Restated Credit Agreement that moves the Administrative Agent role from Bank of America to Wells Fargo and extends the facility’s maturity from March 29, 2029 to June 26, 2031.
Globe Life also executed an Amended and Restated Term Loan Agreement with Wells Fargo as Administrative Agent, increasing the loan’s principal amount from $250,000,000 to $450,000,000 and extending the maturity from August 15, 2027 to June 26, 2029. These agreements continue Globe Life’s lending relationships with a group of banks and are filed as Exhibits 10.1 and 10.2.